Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient who was diagnosed with hepatocellular carcinoma, and was accompanied by impossible for radical treatment in disease period or do not reaction for local treatment, and the first time for sorafenib injection.~* Standard of hepatocellular carcinoma diagnosis (2014, The Korean Liver Cancer Association)~  1. Suitable on hepatocellular carcinoma pathologically~ 2. Hepatic nodule size over 1 cm on high-risk patients(hepatitis B virus positive, hepatitis C virus positive and liver cirrhosis) that identified by ultrasonography : In the case of suitable on hepatocellular carcinoma on over in one or two more dynamic contrast enhanced CT, dynamic contrast enhanced MRI, or MRI with Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid(Gd-EOB-DTPA)~ 3. Hepatic nodule size under 1 cm on high-risk patients that identified by ultrasonography : serum Alpha-fetoprotein(AFP) elevated over normal range constantly when hepatitis activity was restrained, and the case of suitable on hepatocellular carcinoma on over in two more the above image diagnoses~Exclusion Criteria:~* Unsuitable on inclusion criteria~* Patient who has had systemic anticancer therapy before (including sorafenib)~* Patient who is receiving another treatment to hepatocellular carcinoma recent 3 weeks (allow to local treatment of metastasis lesion only)~* Pregnant or Breastfeeding~* Urea cream contraindication patient (Acute eczema, Inflammatory dermatopathy and Hypersensitivity on Urea and Methylparaben)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Urea cream 20% (Type: EXPERIMENTAL): 144 patients spread urea cream (urea 20%)
- Placebo (Type: PLACEBO_COMPARATOR): 144 patients spread placebo cream (urea 0%)

Based on this trial design, predict the completion outcome and termination type (if applicable).